Pharmaceuticals and Health Policy: International Perspectives on Provision and Control of Medicines

277 Pages·2022·14.787 MB·English

by  Richard Blum, Andrew Herxheimer, Catherine Stenzl, Jasper Woodcock

ROUTLEDGE LIBRARY EDITIONS:
HEALTH, DISEASE & SOCIETY
Volume 5
PHARMACEUTICALS
AND HEALTH POLICY

PHARMACEUTICALS
AND HEALTH POLICY
International Perspectives
on Provision and Control of
Medicines
Editors
RICHARD BLUM,
ANDREW HERXHEIMER,
CATHERINE STENZL and
JASPER WOODCOCK
First published in 1981 by Croom Helm Ltd.
This edition first published in 2022
by Routledge
4 Park Square, Milton Park, Abingdon, Oxon OX14 4RN
and by Routledge
605 Third Avenue, New York, NY 10158
Routledge is an imprint of the Taylor & Francis Group, an informa
business
© 1981 International Research Group for Drug Legislation and
Programs.
All rights reserved. No part of this book may be reprinted or
reproduced or utilised in any form or by any electronic, mechanical,
or other means, now known or hereafter invented, including
photocopying and recording, or in any information storage or retrieval
system, without permission in writing from the publishers.
Trademark notice: Product or corporate names may be trademarks
or registered trademarks, and are used only for identification and
explanation without intent to infringe.
British Library Cataloguing in Publication Data
A catalogue record for this book is available from the British Library
ISBN: 978-0-367-52469-2 (Set)
ISBN: 978-1-032-25212-4 (Volume 5) (hbk)
ISBN: 978-1-032-25221-6 (Volume 5) (pbk)
ISBN: 978-1-003-28214-3 (Volume 5) (ebk)
DOI: 10.4324/9781003282143
Publisher’s Note
The publisher has gone to great lengths to ensure the quality of this
reprint but points out that some imperfections in the original copies
may be apparent.
Disclaimer
The publisher has made every effort to trace copyright holders and
would welcome correspondence from those they have been unable
to trace.
PHARMACEUTICALS
AND HEALTH POUCY
INTERNATIONAL PERSPECTIVES ON PROVISION AND
CONTROL OF MEDICINES
EDITORS: RICHARD BLUM, ANDREW HERXHEIMER,
CATHERINE STENZL, JASPER WOODCOCK
CROOM HELM LONDON
INTERNATIONAL RESEARCH GROUP FOR DRUG
LEGISLATION AND PROGRAMS
© 1981 International Research Group for Drug Legislation and Programs
Croom Helm Ltd, 2-10 St John's Road, London SW11
British Library Cataloguing in Publication Data
Pharmaceuticals and health policy.
1. Pharmaceutical policy
I. Blum, Richard
II. International Research Group for Drug
Legislation and Programs
^ 1 RA401
To Lynn Pan who kept us all on course
Typeset by Leaper and Card Ltd, Bristol
Printed and bound in Great Britain
by Billing and Sons Limited
Guildford, London, Oxford, Worcester
CONTENTS
Notes on Contributors
Foreword T.A. Lambo
Preface
Introduction 11
1. Medicines - The Interested Parties Jasper Woodcock 27
2. The Use of Medicines for Illness Andrew Herxheimer and
Gerry V. Stimson 36
3. The Introduction of New Drugs Alex Lumbroso 61
4. The Promotion of Prescription Drugs and other Puzzles
Milton Silverman and Mia Lydecker 78
5. Information and Education about Drugs Georges Peters 93
6. Factors Affecting Individual Use of Medicines Richard Blum,
with Kevin Kreitman 122
7. Economic Considerations in the Provision and Use of
Medicines Sanjaya Lall 186
8. The Role of International Organisations in Medicines
Policy Catherine Stenzl 211
9. Coherent Policies on Drugs: Formulation and
Implementation Wilfred Lionel and Andrew Herxheimer 240
Index 268
NOTES ON CONTRIBUTORS
*AnilAgarwal Assistant Director, Earthscan, London.
*MichaelE. Allan Director of Development, TIL (Medical), Ltd.
London.
*Carol Barker Lecturer in Health Services Planning, Nuffield Centre
for Health Services Studies, University of Leeds. Formerly: Cabinet
of Studies, Ministry of Health, Mozambique. Member of the
Therapeutics and Pharmacology Technical Committee.
Richard H. Blum Chairman of the International Research Group for
Drug Legislation and Programs. Formerly: Consulting Professor of
Psychology, Director, Drug Program, School of Law, Stanford
University. Former US delegate to the UN Narcotics Commission.
*Kettil Bruun Research Director of the Finnish Foundation for
Alcohol Studies, Helsinki.
* Allan E. Dyer Assistant Deputy Minister, Ministry of Health, Ontario.
*Klaus-Wolfvon Eickstedt Director and Professor, Institute for
Drugs, Bundesgesundheitsamt, Berlin
*Katherine Elliott Assistant Director, The Ciba Foundation, London.
*MichaelJ. Flynn Medical Adviser, TIL (Medical), Ltd. London.
*Hans Friebel Chairman, Arzneimittelkommission der Deutschen
Aerzteschaft, Cologne.
*Gordon R. Fryers Consultant Director of Medical Affairs, Proprietary
Association of Great Britain.
*Matthew Gwee Senior Lecturer in Pharmacology, University of
Singapore.
Notes on Contributors
*Elina Hemminki Senior Assistant, Department of Public Health
Sciences, University of Tampere, Finland.
Andrew Herxheimer Senior Lecturer in Clinical Pharmacology and
Therapeutics, Charing Cross Hospital Medical School, London
University. Chairman of Medical Working Group, International
Organization of Consumer Unions. Editor, Drug and Therapeutics
Bulletin.
"'Jorge Katz Director, IDB/ECLA Research Project on Technology
in Latin America (Inter American Development Bank/UN Economic
Commission for Latin America), Buenos Aires.
*Erich Kaufer Professor of Economics, Institut fiir Wirtschaftstheorie
und Wirtschaftspolitik der Universitat Innsbruck.
Kevin Kreitman Assistant in the socio-psycho-pharmacology project,
Program in drug and community studies, Stanford University.
Sanjaya Lall Senior Research Officer, Institute of Economics and
Statistics, University of Oxford. Consultant for the United Nations
Conference for Trade and Development, the UN Industrial
Development Organization, the UN Centre on Transnational
Corporations, the International Labour Office and the World Bank.
*Louis Lasagna Professor of Pharmacology and Toxicology, University
of Rochester.
*Desmond Laurence Professor of Pharmacology and Therapeutics,
School of Medicine, University College, London.
*John Lilja Head, Department of Social Pharmacy, Uppsala
University.
Wilfred Lionel Associate Professor of Pharmacology, University of
Colombo. Secretary, Committee for the Approval of Drugs, Ministry
of Health, Sri Lanka.
Alex Lumbroso Managing Director, Laboratoires Manceau SA, Massy,
France.